Skip to main content

Table 2 Between the two groups of clinical data and glucose control comparison

From: Poor short-term glycemic control in patients with type 2 diabetes impairs the intestinal mucosal barrier: a prospective, single-center, observational study

  Low groups (< 12.31u/l, n = 33) High groups (12.31 ≥ u/l, n = 33) Statistics P
Male [n(%)] 16 (48.5) 22 (66.7) x2 = 2.233 0.135
Age [(Mean ± SD), years] 62.3 ± 11.1 59.5 ± 12.5 t = 0.990 0.326
Hypertension [n(%)] 21 (63.6) 19 (57.6) x2 = 0.254 0.614
Smoking [n(%)] 5 (15.2) 11 (33.3) x2 = 2.970 0.085
Positive family history [n(%)] 7 (21.2) 7 (21.2) 1.000
BMI [(Mean ± SD), Kg/M2] 25.0 ± 4.4 25.2 ± 3.4 t = − 0.176 0.861
Diabetes history [(Mean ± SD), mouth] 9.0 (2~15.5) 5.0 (1.0~10.0) z = −1.649 0.099
hs-CRP [M(Q1~Q3), mmol/l] 2.1 (0.5~6.6) 1.8 (0.5~6.7) z = −0.250 0.802
Medications [n(%)]
 Insulin 11.0 (33.3) 10.0 (30.3) x2 = 0.070 0.792
 Metformin 17.0 (51.5) 15.0 (45.5) x2 = 0.243 0.622
 α-glucosidase inhibitor 12.0 (36.4) 17.0 (51.5) x2 = 1.538 0.215
 Sulfonylureas 2.0 (6.1) 7.0 (21.2) 0.149
 Glinide 1.0 (3.0) 4.0 (12.1) 0.355
 DPP-4 inhibitor 0 (0.0) 1 (3.0) 1.000
Glucose control data
 FPG [M(Q1~Q3), mmol/l] 8.6 (6.8~12.9) 8.8 (7.5~11.1) z = − 0.023 0.982
 2h PBG [M(Q1~Q3), mmol/l] 12.8 (10.6~18.1) 17.0 (15.2~20.8) z = − 1.858 0.063
 DGA [M(Q1~Q3), mmol/l] 11.0 (9.0~15.0) 11.9 (10.1~13.7) z = − 0.301 0.763
 HbAlc [M(Q1~Q3), %] 9.2 (8.2~10.5) 8.2 (8.2~9.4) z = − 1.320 0.187
 GA [M(Q1~Q3), %] 23.3 (19.3~27.2) 25.8 (20.0~36.3) z = − 1.247 0.212
Glucose fluctuations of Short-term
 SDBG [M(Q1~Q3), mmol/l] 2.1 (1.6~2.5) 2.9 (2.0~3.3) z = − 2.520 0.012
 PPGE [M(Q1~Q3), mmol/l] 2.8 (1.8~3.1) 2.2 (1.9~3.8) z = − 0.917 0.359
 LAGE [M(Q1~Q3), mmol/l] 5.9 (4.3~7.4) 7.5 (5.4~8.9) z = − 2.123 0.034
 SDBG < 2.0 mmol/l [n(%)] 15.0 (45.5) 9.0 (27.3) x2 = 2.357 0.125
 PPGE < 2.2 mmol/l [n(%)] 15.0 (45.5) 11.0 (33.3) x2 = 1.015 0.314
 LAGE< 4.4 mmol/l [n(%)] 9.0 (27.3) 4.0 (12.1) x2 = 2.395 0.122
  1. DGA Daily glucose average,FPG:Fasting Plasma Glucose, PBG:Postprandial Blood Glucose, SDBG Standard Deviation Of Blood Glucose, PPGE Postprandial Glucose Excursion, LAGE Largest amplitude of glycemic excursions, BMI Body Mass Index, HbAlc Glycosylated hemoglobin, GA glycated albumin, hs-CRP high-sensitivity C-reactive protein